Provided by Tiger Trade Technology Pte. Ltd.

Evommune

6.04
-0.1850-2.97%
Volume:138.58K
Turnover:846.23K
Market Cap:219.02M
PE:-2.31
High:6.25
Open:6.25
Low:6.02
Close:6.22
52wk High:33.20
52wk Low:6.02
Shares:36.29M
Float Shares:19.98M
Volume Ratio:0.25
T/O Rate:0.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6090
EPS(LYR):-11.2228
ROE:-52.11%
ROA:-31.99%
PB:0.79
PE(LYR):-0.54

Loading ...

Oct 01, 2026

Major Issues Report

Form 8-K - Current report
Sep 23, 2026

Major Issues Report

Form 8-K - Current report
Sep 15, 2026

Major Issues Report

Form 8-K - Current report
Sep 09, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Aug 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2026

Major Issues Report

Form 8-K - Current report
Jul 16, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jun 29, 2026

Major Issues Report

Form 8-K - Current report
Jun 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2026

Major Issues Report

Form 8-K - Current report
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2026

Major Issues Report

Form 8-K - Current report